COGT Earnings

Quarterly EPS
$-0.50
Q4 2024
$-0.52
Q1 2025
$-0.53
Q2 2025
$-0.50
Q3 2025
$-0.59
Q4 2025
$-0.53
Q1 2026
$-0.52
Q2 2026
$-0.59
Q3 2026
Latest RevenueN/A
Latest Net Income-111426000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.590-111426000—-18.0%
Q2 2026-$0.520-96405000—+1.9%
Q1 2026-$0.530-97352000—-1.9%
Q4 2025-$0.590-102492000—-18.0%
Q3 2025-$0.500-80930000—+3.8%
Q2 2025-$0.530-73529000—-23.3%
Q1 2025-$0.520-71986000—-6.1%
Q4 2024-$0.500-67927000—-163.2%
Q3 2024-$0.520-70634000——
Q2 2024-$0.430-58950000——
Q1 2024-$0.490-58348000——
Q4 2023-$0.190-54365000——
Cogent Biosciences (COGT) — Earnings